You are here
AusPAR: Adalimumab
Related information
Australian Public Assessment Report
3 December 2021
AusPAR | |
---|---|
Active Ingredient | Adalimumab
|
Product Name | Hulio
|
Sponsor | Alphapharm Pty Limited
|
Submission Number | PM-2020-01807-1-3
|
Submission Type | New biosimilar medicine
|
Decision | Approved
|
AusPAR Date | 22 November 2021
|
Publication Date | 3 December 2021 |